NCT00475865 - Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis | Biotech Hunter

Enrollment

123

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Multiple Sclerosis

Interventions

DRUG

Teriflunomide

"Film-coated tablet~Oral administration"

DRUG

Placebo (for teriflunomide)

"Film-coated tablet~Oral administration"

DRUG

Glatiramer Acetate (GA)

Solution in prefilled syringe for subcutaneous injection

Trial Locations (6)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Vienna

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Guildford